These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2008418)
1. 5-hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries. Jansen I; Blackburn T; Eriksen K; Edvinsson L Pharmacol Toxicol; 1991 Jan; 68(1):8-13. PubMed ID: 2008418 [TBL] [Abstract][Full Text] [Related]
2. ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system. Kaumann AJ; Frenken M J Pharmacol Exp Ther; 1988 Jun; 245(3):1010-5. PubMed ID: 3385635 [TBL] [Abstract][Full Text] [Related]
3. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors. Kaumann AJ; Frenken M Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064 [TBL] [Abstract][Full Text] [Related]
4. Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system. Frenken M; Kaumann AJ J Pharmacol Exp Ther; 1989 Aug; 250(2):707-13. PubMed ID: 2760851 [TBL] [Abstract][Full Text] [Related]
5. Characterization of 5-hydroxytryptamine receptors in goat cerebral arteries. Miranda FJ; Torregrosa G; Salom JB; Alabadí JA; Jover T; Barberá MD; Alborch E Gen Pharmacol; 1995 Oct; 26(6):1267-72. PubMed ID: 7590117 [TBL] [Abstract][Full Text] [Related]
6. In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist. Blackburn TP; Thornber CW; Pearce RJ; Cox B Eur J Pharmacol; 1988 Jun; 150(3):247-56. PubMed ID: 3416910 [TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Jansen I; Olesen J; Edvinsson L Acta Physiol Scand; 1993 Feb; 147(2):141-50. PubMed ID: 8386424 [TBL] [Abstract][Full Text] [Related]
8. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery. Hamel E; Robert JP; Young AR; MacKenzie ET J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950 [TBL] [Abstract][Full Text] [Related]
10. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators. Frenken M; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629 [TBL] [Abstract][Full Text] [Related]
11. 5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery. MacLennan SJ; Whittle MJ; McGrath JC Br J Pharmacol; 1989 Jul; 97(3):921-33. PubMed ID: 2503229 [TBL] [Abstract][Full Text] [Related]
12. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141 [TBL] [Abstract][Full Text] [Related]
13. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124 [TBL] [Abstract][Full Text] [Related]
14. 5-HT1 receptors mediating contraction in bovine cerebral arteries: a model for human cerebrovascular '5-HT1D beta' receptors. Hamel E; Grégoire L; Lau B Eur J Pharmacol; 1993 Sep; 242(1):75-82. PubMed ID: 8223939 [TBL] [Abstract][Full Text] [Related]
15. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro. Kemp BK; Cocks TM Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247 [TBL] [Abstract][Full Text] [Related]
16. Methylergometrine antagonizes 5 HT in the temporal artery. Tfelt-Hansen P; Jansen I; Edvinsson L Eur J Clin Pharmacol; 1987; 33(1):77-9. PubMed ID: 3691600 [TBL] [Abstract][Full Text] [Related]
17. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors. Kaumann AJ; Frenken M; Posival H; Brown AM Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. Toda N; Okamura T J Pharmacol Exp Ther; 1990 May; 253(2):676-82. PubMed ID: 2338652 [TBL] [Abstract][Full Text] [Related]
19. A pharmacological comparison of the receptors mediating contractile responses to 5-hydroxytryptamine in the rat isolated caudal artery and fundic strip. Growcott JW; Cox B; Blackburn TP J Pharm Pharmacol; 1993 Oct; 45(10):876-81. PubMed ID: 7904626 [TBL] [Abstract][Full Text] [Related]
20. Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins. Reviriego J; Marín J Br J Pharmacol; 1989 Apr; 96(4):961-9. PubMed ID: 2743086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]